Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the Russell 2000 Index during the fourth quarter as well as in FY2025. The stock selection drove the underperformance of the Strategy in the quarter. The strategy’s emphasis on high-quality stocks lagged behind broader market trends. However, the firm expects the environment to be more favorable for high-quality businesses ...

United Airlines Holdings Inc. (NASDAQ:UAL) is one of the best large cap value stocks to buy in 2026. On January 13, Goldman Sachs analyst Catherine O’Brien raised the firm’s price target on United Airlines to $129 from $115, while keeping a Buy rating. The firm has reduced the Q4 2025 net income forecast for the industry by 15% due to the significant economic drag from the government shutdown. Goldman Sachs specifically highlighted that the 43-day impasse disrupted federal spending and hit consumer liquidi ...

EOG Resources Inc. (NYSE:EOG) is one of the best large cap value stocks to buy in 2026. On January 16, Scotiabank analyst Paul Cheng lowered the firm’s price target on EOG Resources to $123 from $130 with a Sector Perform rating. The firm is adjusting its price targets for big US oil, refining, and drilling companies. It expects this quarter’s earnings to be business as usual because there weren’t any bad winter storms to slow down production. On the same day, KeyBanc downgraded EOG Resources to Sector We ...

Devon Energy Corporation (NYSE:DVN) is one of the best large cap value stocks to buy in 2026. On January 16, Bank of America raised its price target on Devon Energy to $46 from $45 while maintaining a Buy rating. Heading into 2026, the firm maintains a cautious stance on the broader oil market. BofA is prioritizing companies with resilient portfolios and low breakeven points. However, Scotiabank downgraded Devon Energy to Sector Perform from Sector Outperform, while lowering the price target to $41 from $ ...

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the best mid-cap growth stocks to buy right now. On January 13, Baird analyst Brian Skorney raised the firm’s price target on Mirum Pharmaceuticals to $95 from $81, while maintaining an Outperform rating. This revision came as the firm updated its valuation model after preliminary results delivered a beat-and-raise on earnings and guidance. The stronger-than-expected data provides a solid foundation heading into a high-activity year in 2026. Furthermore, ...

Group 1 - Halozyme Therapeutics Inc. is identified as a promising mid-cap growth stock, with TD Cowen raising its price target from $79 to $90 while maintaining a Buy rating [1] - Investor sentiment is shifting positively ahead of Q4 2025 earnings, with 2026 guidance being crucial for positioning in a sector-wide recovery [1][3] - A global collaboration and exclusive license agreement was announced between Takeda and Halozyme, granting Takeda access to Halozyme's ENHANZE drug-delivery technology for vedolizumab [2][3] Group 2 - The agreement allows Takeda to utilize Halozyme's recombinant human hyaluronidase PH20 enzyme to enhance the subcutaneous delivery of vedolizumab, aiming to improve treatment flexibility and reduce therapy management time [3] - Halozyme is a biopharmaceutical company focused on researching, developing, and commercializing proprietary enzymes and devices both in the US and internationally [4]

Company Overview - Opendoor Technologies Inc. operates a digital platform that facilitates the buying and selling of homes directly, allowing users to list their homes or connect with buyers through its marketplace [2]. Investment Sentiment - Jim Cramer has highlighted Opendoor as a speculative stock, suggesting that while it may not be profitable currently, it could still be a viable investment option [1]. - Cramer expressed skepticism regarding the stock's high valuation given the company's lack of profitability, indicating a need for the company to generate earnings before he would fully endorse it [2]. Comparative Analysis - There is a belief that while Opendoor has potential, certain AI stocks may offer greater upside potential and carry less downside risk, suggesting a competitive landscape for investment opportunities [3].

Core Viewpoint - JetBlue Airways Corporation (NASDAQ:JBLU) has faced significant challenges, including a recent drop in stock value due to poor earnings and outlook, leading to a loss of over 25% in a single session [2]. Group 1: Stock Performance - The stock of JetBlue has declined by over 8% since the negative earnings report was aired [3]. - The company experienced a dramatic loss of over 25% in stock value in one trading session following disappointing earnings and outlook [2]. Group 2: Market Comparison - Jim Cramer expressed a preference for owning shares in cruise lines over airlines, indicating a lack of confidence in JetBlue compared to other companies in the sector [2]. - Cramer highlighted United Airlines as a strong competitor, praising its CEO Scott Kirby, which suggests a competitive disadvantage for JetBlue [1]. Group 3: Investment Perspective - While JetBlue is acknowledged as a potential investment, there are suggestions that certain AI stocks may offer greater upside potential and carry less downside risk [3].

We recently published 10 Big Names Leaving Wall Street Behind; 7 Are Hitting Record Highs. Transocean Ltd. (NYSE:RIG) was one of the worst performers on Wednesday. Transocean climbed to a new 52-week high of $4.72 on Wednesday, up 9.76 percent, as investors cheered the successful first phase of drilling exploration on ConocoPhilips’ Otway Basin project offshore Victoria, Australia. At market close, the stock trimmed gains to end the day just up by 7.67 percent at $4.63 apiece. In an updated report, Con ...

Company Overview - Palomar Holdings, Inc. (PLMR) is a specialty insurance company focused on property and casualty products, including earthquake, inland marine, and excess and surplus lines [4] Analyst Ratings and Price Targets - JPMorgan raised the price target for PLMR to $155 from $145 while maintaining an Overweight rating, indicating confidence in the company's growth potential despite challenging industry fundamentals [2] - Keefe, Bruyette & Woods also raised its price target on PLMR to $171 from $170 and reiterated an Outperform rating, reflecting positive analyst sentiment towards the stock [3] Industry Context - The property and casualty (P&C) insurance industry is facing worsening fundamentals, but pricing, margin, and growth concerns appear to be largely priced in according to analysts [2]